Abbott recalls some liquid baby formula over bottle defect
...(Reuters) - Abbott Laboratories said on Friday it was recalling......…
112,120€
0,27%
Echtzeit-Aktienkurs Abbott Laboratories
Bid:
Ask:
Nachrichten zur Abbott Laboratories Aktie
Abbott recalls some ready-to-feed baby formula over bottle defect
...Oct 14 (Reuters) - Abbott Laboratories said on
Friday......…
ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 13, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company")…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (NYSE: ABT)
NEW YORK, Oct. 12, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Abbott Laboratories.…
XETR : DIVIDEND/INTEREST INFORMATION - 13.10.2022 - US0028241000
Das Instrument ABL US0028241000 ABBOTT LABS EQUITY wird cum Dividende/Zinsen gehandelt am 12.10.2022 und ex Dividende/Zinsen am 13.10.2022
The instrument ABL…
Better Bear-Market Buy: Abbott Laboratories vs. AbbVie Stock
Its parent vs. child in this bear-market matchup....…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT
NEW YORK, Oct. 10, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott"…
ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
NEW ORLEANS, Oct. 7, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October…
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
Abbott Laboratories: Kursziel gesenkt
New York (www.aktiencheck.de) - Rating-Update:
Joanne Wuensch, Analystin der Citigroup, stuft die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol:…
ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 6, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company")…
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Abbott Laboratories - ABT
CEDARHURST, N.Y., Oct. 5, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to…
ABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Shareholders
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott"…
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Attention Abbott Laboratories ("Abbott") (NYSE: ABT) shareholders: The Law Offices of Vincent Wong…
Übernahmespekulationen treiben Aktien von Biotechfirma Actelion hoch
Zürich/Frankfurt (Reuters) - Wiederaufgeflammte Übernahmespekulationen haben die Aktien der Schweizer Biotechnologiefirma Actelion auf ein Rekordhoch gehoben.
Vertreter von Europas größtem…